FULC
FULC
NASDAQ · Pharmaceuticals

Fulcrum Therapeutics Inc

$3.76
-0.01 (-0.27%)
As of Sep 20, 10:22 PM ET ·
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 64%
Sell 4 36%
Price Target
Analyst Price Target +1,415.4% upside
Low Target $37.54
Average Target $56.98
High Target $60.88
Current Price $3.76
Current
$3.76
Target
$56.98
$37.54 $56.98 avg $60.88
Scenario Analysis
Bear Case
$37.54
898.4%
Low target
Base Case
$56.98
+1,415.4%
Avg target
Bull Case
$60.88
+1,519.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$15.74
-76.1% from high
52-Week Low
$2.83
+32.9% from low
Target vs 52W High
$56.98
+262.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%